EP1126877A4 - Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate - Google Patents

Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate

Info

Publication number
EP1126877A4
EP1126877A4 EP99954867A EP99954867A EP1126877A4 EP 1126877 A4 EP1126877 A4 EP 1126877A4 EP 99954867 A EP99954867 A EP 99954867A EP 99954867 A EP99954867 A EP 99954867A EP 1126877 A4 EP1126877 A4 EP 1126877A4
Authority
EP
European Patent Office
Prior art keywords
staging
diagnosing
imaging
monitoring
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99954867A
Other languages
German (de)
English (en)
Other versions
EP1126877A1 (fr
Inventor
Shujath M Ali
Yongming Sun
Susana Salceda
Herve Recipon
Robert Cafferkey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1126877A1 publication Critical patent/EP1126877A1/fr
Publication of EP1126877A4 publication Critical patent/EP1126877A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP99954867A 1998-10-19 1999-10-18 Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate Withdrawn EP1126877A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10474198P 1998-10-19 1998-10-19
US104741P 1998-10-19
PCT/US1999/023764 WO2000023108A1 (fr) 1998-10-19 1999-10-18 Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate

Publications (2)

Publication Number Publication Date
EP1126877A1 EP1126877A1 (fr) 2001-08-29
EP1126877A4 true EP1126877A4 (fr) 2003-05-28

Family

ID=22302121

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99954867A Withdrawn EP1126877A4 (fr) 1998-10-19 1999-10-18 Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate

Country Status (4)

Country Link
EP (1) EP1126877A4 (fr)
JP (1) JP2002527757A (fr)
CA (1) CA2347085A1 (fr)
WO (1) WO2000023108A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1251139A3 (fr) * 1998-04-08 2002-12-18 Genentech, Inc. Protéine semblable à mendin humain et acides nucléiques le codant
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1466977A1 (fr) * 1999-03-08 2004-10-13 Genentech, Inc. Procédés et compositions pour l'inhibition de la croissance de cellules néoplastiques
US6682902B2 (en) 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
JP2004520810A (ja) * 2000-08-24 2004-07-15 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
NZ544911A (en) 2003-07-22 2008-12-24 Schering Ag RG1 antibodies and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045442A2 (fr) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Homologues de f-spondine secretee

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045442A2 (fr) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Homologues de f-spondine secretee

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0023108A1 *

Also Published As

Publication number Publication date
EP1126877A1 (fr) 2001-08-29
CA2347085A1 (fr) 2000-04-27
JP2002527757A (ja) 2002-08-27
WO2000023108A1 (fr) 2000-04-27

Similar Documents

Publication Publication Date Title
EP1239874A4 (fr) Methode de diagnostic, de controle, de stadification, d'imagerie et de traitement du cancer de la prostate
EP1105528A4 (fr) Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
EP1131095A4 (fr) Methode permettant de diagnostiquer, de surveiller, de classer par stades, de visualiser et de traiter le cancer de la prostate
AU2001250932A8 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU6688598A (en) Method for diagnosing and staging prostate cancer
MXPA01008794A (es) Metodo para diagnosticar y verificar carcinomas de pecho malignos.
EP1117842A4 (fr) Methodes pour choisir des traitements contre le cancer de la prostate ou pour traiter le cancer de la prostate
AP2003002875A0 (en) Apparatus and method for treatment of water.
EP1090291A4 (fr) Procede de diagnostic precoce du cancer et de determination de pronostic correspondant
EP0975803A4 (fr) Methode d'evaluation d'un cancer de la prostate
AU2001251013A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1082459A4 (fr) Technique de diagnostic, de suivi et de stadification du cancer du poumon
EP1175616A4 (fr) Procedes pour le diagnostic et le traitement de tumeurs metastatiques de la prostate
EP1267934A4 (fr) Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein
EP1114679A4 (fr) Procede de production de sol, unite de traitement de sol, procede de traitement et unite de traitement afferente
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
IL142340A0 (en) Methods for identification, diagnosis, and treatment of breast cancer
EP1107798A4 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer du colon
EP1104486A4 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
AU4003597A (en) Methods of diagnosing and treating cancer
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
EP1126877A4 (fr) Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate
EP1082460A4 (fr) Nouveau procede de diagnostic, de surveillance et de stadification du cancer de la prostate
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010518

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20030414

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 39/395 B

Ipc: 7C 12Q 1/68 B

Ipc: 7G 01N 33/574 A

17Q First examination report despatched

Effective date: 20030829

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050118